Page last updated: 2024-11-02

pindolol and Acute Hepatic Failure

pindolol has been researched along with Acute Hepatic Failure in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Research Excerpts

ExcerptRelevanceReference
" In addition, binding sites for the noradrenergic receptor subtype ligands, [3H]-prazosin (alpha1 sites), [3H]-RX821002 (alpha2 sites), and [125]I-iodopindolol (beta sites), were assessed using quantitative receptor autoradiography in regions of the brains of rats at coma stage of acute liver failure and of control groups of animals."3.70Evidence for altered central noradrenergic function in experimental acute liver failure in the rat. ( Butterworth, RF; Buu, PN; Michalak, A; Rose, C, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Michalak, A1
Rose, C1
Buu, PN1
Butterworth, RF1

Other Studies

1 other study available for pindolol and Acute Hepatic Failure

ArticleYear
Evidence for altered central noradrenergic function in experimental acute liver failure in the rat.
    Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Autoradiography; Cerebral Cortex

1998